ITGA2 and central nervous system cancer: Moreover, a number of studies have shown that the loss of ITGA2 can reduce the proliferation, invasion and adhesion of glioma cells, and can be targeted to overcome the resistance of glioma cells to radiotherapy and chemotherapy, thereby prolonging the survival of patients (10).